<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03333564</url>
  </required_header>
  <id_info>
    <org_study_id>DRGS-2014-2015-165</org_study_id>
    <nct_id>NCT03333564</nct_id>
  </id_info>
  <brief_title>Effect of Vitamin D3 and Omega-3FA on Estradiol</brief_title>
  <official_title>Effect of Vitamin D3 and Omega-3FA on Estradiol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Applied Science Private University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Applied Science Private University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of vitamin D3 and omega-3 Fatty acids on estradiol levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The data about effect of vitamin D3 (VD3) and omega-3 fatty acids (omega-3FA) on serum levels
      of estradiol (E2) are scarce and conflicting and nothing is published in the literature about
      the effect of the combination of VD3 and omega-3FA on the E2 levels.

      This study was conducted to investigate effect of VD3 and omega-3FA alone and with each other
      on serum E2 levels in premenopausal females with vitamin D deficiency (VDD).

      This randomized, placebo-controlled clinical trial was designed to test effects of 50,000 IU
      VD3 weekly and 300 mg omega-3FA daily for eight weeks, separately and with each other, on the
      mid-follicular serum levels of E2 and 25-hydroxy vitamin D (25OHD). This study was conducted
      during winter in 86 healthy premenopausal Jordanian females with VDD with a mean age of (32.8
      Â± 8.9) years. Fasting serum levels for 25OHD, E2, PTH (parathyroid hormon), calcium,
      phosphate, ALT (alanine aminotransferase), and urea were assessed at baseline and the end of
      the trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma concentrations of 25-hydroxyvitamin D, estradiol</measure>
    <time_frame>8 weeks</time_frame>
    <description>Concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma concentrations of PTH, Ca</measure>
    <time_frame>8 weeks</time_frame>
    <description>Concentration</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">116</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>VD3 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>treated with 50,000 IU VD3 / week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>omega3-FA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1000 mg wild salmon and fish oil complex (contains 300 mg of omega3-FA) once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VD3 and Omega-3FA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50,000 IU VD3 / week and 1000 mg wild salmon and fish oil complex (contains 300 mg of omega-3FA) once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No intervention was given</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>VD3</intervention_name>
    <description>50,000 IU VD3 / week for 8 weeks</description>
    <arm_group_label>VD3 group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Omega3-FA</intervention_name>
    <description>300 mg of omega3-FA once daily for 8 weeks</description>
    <arm_group_label>omega3-FA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>VD3 and Omega-3FA</intervention_name>
    <description>50,000 IU VD3 / week for 8 weeks and 300 mg of omega-3FA once daily for 8 weeks</description>
    <arm_group_label>VD3 and Omega-3FA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>No intervention was given</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premenopausal females

          -  Medical diagnosis of vitamin D deficiency (VD &lt; 30 ng / ml)

        Exclusion Criteria:

          -  Women previously diagnosed with any chronic disease such as kidney diseases were
             excluded from the study due to the effect of prolonged administration of VD3 on kidney
             stones formation. Women who are pregnant, breastfeeding or using hormonal
             contraceptives were also excluded.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Premenopausal females</gender_description>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud S Abu-Samak, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Applied Science Private University</affiliation>
  </overall_official>
  <reference>
    <citation>Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008 Apr;87(4):1080S-6S. Review.</citation>
    <PMID>18400738</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2017</study_first_submitted>
  <study_first_submitted_qc>November 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2017</study_first_posted>
  <last_update_submitted>November 3, 2017</last_update_submitted>
  <last_update_submitted_qc>November 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D3</keyword>
  <keyword>Vitamin D deficiency</keyword>
  <keyword>estradiol</keyword>
  <keyword>omega-3 fatty acids</keyword>
  <keyword>menopausal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Estradiol</mesh_term>
    <mesh_term>Polyestradiol phosphate</mesh_term>
    <mesh_term>Estradiol 3-benzoate</mesh_term>
    <mesh_term>Estradiol 17 beta-cypionate</mesh_term>
    <mesh_term>Estradiol valerate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all IPD that underlie results in a publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

